Zimovetz EA, Wolowacz SE, Classi PM, Birt J. Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review. Cost Eff Resour Alloc. 2012 Feb 1;10(1):1.
Rofail D, Kitchen H, Heyes A, Heron L, Sacco P. Cognitive impairment associated with schizophrenia: the humanistic and economic burden. Poster presented at the American Neurological Association; 2010. San Francisco, CA.
Khan SB, Zagar AJ, Hayes CP, DiBenedetti DB, Zhou X, Price M, Van Brunt DL. Assessment of type 2 Diabetes mellitus patients with and without symptoms of ADHD: patient characteristics and resource utilization data from an internet-based survey. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 14th Annual International Meeting; May 15, 2009. Orlando, FL. [abstract] Value Health. 2009 May 1; 12(3):A181-2.